Sort by
Search results
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.
BIOPHEN Heparin anti-IIa (2-stages kit)
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.
Emicizumab Controls
Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Emicizumab Calibrator
Calibration of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
LIAPHEN vWF:Ag
Diagnosis of von Willebrand disease. Determination of high vWF antigen levels associated with cardiovascular diseases.
LIAPHEN Fibrinogen
Assay of fibrinogen in human citrated plasma or in cell culture supernatants.
LIAPHEN Antithrombin
Assay of AT in human citrated plasma.
LIAPHEN Free Protein S
Determination of free protein S antigen (free PS: Ag) in human citrated plasma.
LIAPHEN™ Protein C
Quantitative determination of protein C antigen in human citrated plasma.
LIAPHEN Antithrombin
Assay of AT in human citrated plasma.